236 related articles for article (PubMed ID: 16728429)
1. Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Park SK
Nephrol Dial Transplant; 2006 Aug; 21(8):2096-105. PubMed ID: 16728429
[TBL] [Abstract][Full Text] [Related]
2. Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury.
Lee S; Moon SO; Kim W; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Lee SY; Park SK
Nephrol Dial Transplant; 2006 Aug; 21(8):2085-95. PubMed ID: 16705027
[TBL] [Abstract][Full Text] [Related]
3. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
4. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.
Lee S; Kim W; Kang KP; Moon SO; Sung MJ; Kim DH; Kim HJ; Park SK
Nephrol Dial Transplant; 2005 Jun; 20(6):1057-65. PubMed ID: 15797891
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
9. The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Korolczuk A; Maciejewski M; Smolen A; Dudka J; Czechowska G; Widelska I
J Physiol Pharmacol; 2014 Dec; 65(6):867-76. PubMed ID: 25554991
[TBL] [Abstract][Full Text] [Related]
10. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
Ramesh G; Reeves WB
Kidney Int; 2004 Feb; 65(2):490-9. PubMed ID: 14717919
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages.
Caito S; Yang SR; Kode A; Edirisinghe I; Rajendrasozhan S; Phipps RP; Rahman I
Antioxid Redox Signal; 2008 Feb; 10(2):253-60. PubMed ID: 17970647
[TBL] [Abstract][Full Text] [Related]
14. IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity.
Kim MG; Yang HN; Kim HW; Jo SK; Cho WY; Kim HK
J Korean Med Sci; 2010 Apr; 25(4):557-63. PubMed ID: 20357998
[TBL] [Abstract][Full Text] [Related]
15. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone protects against cisplatin induced nephrotoxicity in rats and potentiates its anticancer activity against human renal adenocarcinoma cell lines.
Mahmoud MF; El Shazly SM
Food Chem Toxicol; 2013 Jan; 51():114-22. PubMed ID: 22989705
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
Tikoo K; Kumar P; Gupta J
BMC Cancer; 2009 Apr; 9():107. PubMed ID: 19356226
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation.
Kang KP; Kim DH; Jung YJ; Lee AS; Lee S; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
Nephrol Dial Transplant; 2009 Oct; 24(10):3012-20. PubMed ID: 19474282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
